Company Details
sanofi
88,229
4,270,853
3254
sanofi.com
42
SAN_2889324
Completed

Sanofi Company CyberSecurity Posture
sanofi.comWe are Sanofi, an innovative global healthcare company. We chase the miracles of science to improve people’s lives. Our team, across some 100 countries, is dedicated to transforming the practice of medicine by working to turn the impossible into the possible. We provide potentially life-changing treatment options and life-saving vaccine protection to millions of people globally, while putting sustainability and social responsibility at the center of our ambitions. Interactions with this account must comply with the Terms: https://bit.ly/sanofi-terms
Company Details
sanofi
88,229
4,270,853
3254
sanofi.com
42
SAN_2889324
Completed
Between 800 and 849

Sanofi Global Score (TPRM)XXXX



No incidents recorded for Sanofi in 2025.
No incidents recorded for Sanofi in 2025.
No incidents recorded for Sanofi in 2025.
Sanofi cyber incidents detection timeline including parent company and subsidiaries

We are Sanofi, an innovative global healthcare company. We chase the miracles of science to improve people’s lives. Our team, across some 100 countries, is dedicated to transforming the practice of medicine by working to turn the impossible into the possible. We provide potentially life-changing treatment options and life-saving vaccine protection to millions of people globally, while putting sustainability and social responsibility at the center of our ambitions. Interactions with this account must comply with the Terms: https://bit.ly/sanofi-terms


Parexel is among the world’s largest clinical research organizations (CROs), providing the full range of Phase I to IV clinical development services to help life-saving treatments reach patients faster. Leveraging the breadth of our clinical, regulatory and therapeutic expertise, our team of more th

Intas is one of the leading multinational pharmaceutical formulation development, manufacturing, and marketing organization in the world. It has been growing at 19% CAGR and crossed the $2.5 billion mark in the past financial year. The company has set up a network of subsidiaries, under the name Acc

The Menarini Group is a leading international pharmaceutical and diagnostics company, present in 140 countries worldwide, with a turnover of 4,37 Billion euro and more than 17,000 employees. With 9 centers for Research & Development, Menarini’s products are present in the most important therapeutic

Championing the missions that matter™. Catalent, Inc. is a leading global contract development and manufacturing organization (CDMO) and trusted partner to pharma, biotech, and consumer health companies worldwide. We put patients first in everything we do, helping people live better and healthier li

Established in 1966, PT Kalbe Farma Tbk. (“the Company” or “Kalbe”) has gone a long way from its humble beginnings as a garage-operated pharmaceutical business in North Jakarta. It has expanded by strategic acquisitions of pharmaceutical companies, building a leading brand positioning and reaching t

As a global healthcare company, Fresenius Kabi is Committed to Life. The company’s products, technologies, and services are used for the therapy and care of critically and chronically ill patients. With over 41,000 employees and present in over 100 countries, Fresenius Kabi’s expansive product portf
AbbVie is a global biopharmaceutical company focused on creating medicines and solutions that put impact first — for patients, communities, and our world. We aim to address complex health issues and enhance people's lives through our core therapeutic areas: immunology, oncology, neuroscience, eye ca

At UCB, we believe everyone deserves to live the best life they can - as free as possible from the challenges and uncertainty of disease. Our purpose is to support people living with severe central nervous system and immunological conditions by delivering meaningful solutions that go beyond medicine
Novo Nordisk is a leading global healthcare company, founded in 1923 and headquartered in Denmark. Our purpose is to drive change to defeat serious chronic diseases, built upon our heritage in diabetes. We do so by pioneering scientific breakthroughs, expanding access to our medicines, and working t
.png)
French pharmaceutical giant Sanofi announced recently that its Tzield has been approved by China's National Medical Products Administration.
Palo Alto Networks PANW and Check Point SoftwareCHKP are both at the forefront of the cybersecurity space, playing key roles in guarding...
As a Cyber Security Engineer, you will design and implement security architectures, manage and monitor infrastructure, perform vulnerability testing, and...
Weil is advising Sanofi in its acquisition of Blueprint Medicines, a US-based, publicly traded biopharmaceutical company specializing in systemicmastocytosis (...
Clayton Dubilier & Rice is working on a package of commitments amid political concerns that its purchase of a controlling stake in Sanofi's...
Clayton Dubilier & Rice is nearing a deal to acquire Sanofi's consumer health unit for about €15 billion ($16.4 billion), in what would be...
Sanofi has received binding offers for its consumer health division from private equity firms Clayton Dubilier & Rice and PAI Partners,...
Multiple clients of CBIZ Benefits and Insurance Services were affected by a data breach that leaked the personal information of CBIZ's clients' retired...
While the international IT outage caused by cybersecurity specialist CrowdStrike—and subsequently Microsoft—has grounded airlines and forced...

Explore insights on cybersecurity incidents, risk posture, and Rankiteo's assessments.
The official website of Sanofi is http://www.sanofi.com.
According to Rankiteo, Sanofi’s AI-generated cybersecurity score is 826, reflecting their Good security posture.
According to Rankiteo, Sanofi currently holds 0 security badges, indicating that no recognized compliance certifications are currently verified for the organization.
According to Rankiteo, Sanofi is not certified under SOC 2 Type 1.
According to Rankiteo, Sanofi does not hold a SOC 2 Type 2 certification.
According to Rankiteo, Sanofi is not listed as GDPR compliant.
According to Rankiteo, Sanofi does not currently maintain PCI DSS compliance.
According to Rankiteo, Sanofi is not compliant with HIPAA regulations.
According to Rankiteo,Sanofi is not certified under ISO 27001, indicating the absence of a formally recognized information security management framework.
Sanofi operates primarily in the Pharmaceutical Manufacturing industry.
Sanofi employs approximately 88,229 people worldwide.
Sanofi presently has no subsidiaries across any sectors.
Sanofi’s official LinkedIn profile has approximately 4,270,853 followers.
Sanofi is classified under the NAICS code 3254, which corresponds to Pharmaceutical and Medicine Manufacturing.
Yes, Sanofi has an official profile on Crunchbase, which can be accessed here: https://www.crunchbase.com/organization/sanofi.
Yes, Sanofi maintains an official LinkedIn profile, which is actively utilized for branding and talent engagement, which can be accessed here: https://www.linkedin.com/company/sanofi.
As of December 11, 2025, Rankiteo reports that Sanofi has not experienced any cybersecurity incidents.
Sanofi has an estimated 5,412 peer or competitor companies worldwide.
Total Incidents: According to Rankiteo, Sanofi has faced 0 incidents in the past.
Incident Types: The types of cybersecurity incidents that have occurred include .
.png)
FreePBX Endpoint Manager is a module for managing telephony endpoints in FreePBX systems. Versions prior to 16.0.96 and 17.0.1 through 17.0.9 have a weak default password. By default, this is a 6 digit numeric value which can be brute forced. (This is the app_password parameter). Depending on local configuration, this password could be the extension, voicemail, user manager, DPMA or EPM phone admin password. This issue is fixed in versions 16.0.96 and 17.0.10.
Neuron is a PHP framework for creating and orchestrating AI Agents. In versions 2.8.11 and below, the MySQLWriteTool executes arbitrary SQL provided by the caller using PDO::prepare() + execute() without semantic restrictions. This is consistent with the name (“write tool”), but in an LLM/agent context it becomes a high-risk capability: prompt injection or indirect prompt manipulation can cause execution of destructive queries such as DROP TABLE, TRUNCATE, DELETE, ALTER, or privilege-related statements (subject to DB permissions). Deployments that expose an agent with MySQLWriteTool enabled to untrusted input and/or run the tool with a DB user that has broad privileges are impacted. This issue is fixed in version 2.8.12.
Neuron is a PHP framework for creating and orchestrating AI Agents. Versions 2.8.11 and below use MySQLSelectTool, which is vulnerable to Read-Only Bypass. MySQLSelectTool is intended to be a read-only SQL tool (e.g., for LLM agent querying, however, validation based on the first keyword (e.g., SELECT) and a forbidden-keyword list does not block file-writing constructs such as INTO OUTFILE / INTO DUMPFILE. As a result, an attacker who can influence the tool input (e.g., via prompt injection through a public agent endpoint) may write arbitrary files to the DB server if the MySQL/MariaDB account has the FILE privilege and server configuration permits writes to a useful location (e.g., a web-accessible directory). This issue is fixed in version 2.8.12.
Okta Java Management SDK facilitates interactions with the Okta management API. In versions 11.0.0 through 20.0.0, race conditions may arise from concurrent requests using the ApiClient class. This could cause a status code or response header from one request’s response to influence another request’s response. This issue is fixed in version 20.0.1.
The Auth0 Next.js SDK is a library for implementing user authentication in Next.js applications. When using versions 4.11.0 through 4.11.2 and 4.12.0, simultaneous requests on the same client may result in improper lookups in the TokenRequestCache for the request results. This issue is fixed in versions 4.11.2 and 4.12.1.

Get company history
Every week, Rankiteo analyzes billions of signals to give organizations a sharper, faster view of emerging risks. With deeper, more actionable intelligence at their fingertips, security teams can outpace threat actors, respond instantly to Zero-Day attacks, and dramatically shrink their risk exposure window.
Identify exposed access points, detect misconfigured SSL certificates, and uncover vulnerabilities across the network infrastructure.
Gain visibility into the software components used within an organization to detect vulnerabilities, manage risk, and ensure supply chain security.
Monitor and manage all IT assets and their configurations to ensure accurate, real-time visibility across the company's technology environment.
Leverage real-time insights on active threats, malware campaigns, and emerging vulnerabilities to proactively defend against evolving cyberattacks.
